Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Squamous Cell

Explore clinical trials studying Neoplasms, Squamous Cell. Study availability and eligibility vary by location and protocol.

836 public trials 219 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Squamous Cell trial results

Recruiting

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

NCT04915183

Conditions
Carcinoma, Carcinoma, Squamous Cell, Ear Diseases, +15 more
Locations
  • Winship Cancer Institute at Emory University Atlanta, Georgia, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Wilmot Cancer Institute at the University of Rochester Medical Center in New Yor Rochester, New York, United States
View Trial Details
Recruiting

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

NCT05319730

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 4905) Los Angeles, California, United States
  • Hematology-Oncology Associates of Central NY, P.C. ( Site 4925) East Syracuse, New York, United States
  • Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical ( Site 4907) New York, United States
View all 58 locations
View Trial Details
Recruiting

SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma

NCT07700667

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Jilin Cancer Hospital Changchun, China
  • Chengdu Fifth People's Hospital Chengdu, China
  • Sichuan Cancer Hospital & Institute Chengdu, China
  • West China Hospital, Sichuan University Chengdu, China
View all 24 locations
View Trial Details
Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT06084481

Conditions
Adenocarcinoma, Biliary Tract Cancers, Biliary Tract Diseases, +31 more
Locations
  • City of Hope National Medical Center /ID# 258645 Duarte, California, United States
  • University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926 Denver, Colorado, United States
  • Florida Cancer Specialists /ID# 261569 Sarasota, Florida, United States
View all 54 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

NCT07554521

Conditions
Advanced Gastroesophageal Adenocarcinoma, Advanced Unresectable Gastric Adenocarcinoma, Carcinoma, +14 more
Locations
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Bioresearch Partners Holding Hialeah Hospital Hialeah, Florida, United States
  • Florida Clinical Trials Group Plantation Plantation, Florida, United States
  • Florida Clinical Trials Group Tamarac Tamarac, Florida, United States
View Trial Details
Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT07115043

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • Research Site Grand Rapids, Michigan, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Pittsburgh, Pennsylvania, United States
  • Research Site Houston, Texas, United States
View all 13 locations
View Trial Details

Related conditions